H5N1 VLP Vaccine: Interim Phase I data

Medicago Inc. (TSX-V:MDG), Quebec, Quebec Product: H5N1 VLP Vaccine Business: Infectious Molecular target: Influenza antigen Description: Plant-based, virus-like-particle (VLP) vaccine against H5N1 av...